Aurigene Oncology announces phase 1 results for India’s first CAR-T cell therapy in multiple Myeloma Read more
ImmunoACT to lead journey of indigenous CAR-T cell therapy in India but market access a hurdle: GlobalData Read more
US FDA approves Bristol Myers Squibb’s CAR-T cell therapy Breyanzi for relapsed large B-cell lymphoma after one prior therapy Read more
Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health City, Bengaluru Read more